Daniel Skiest to Antifungal Agents
This is a "connection" page, showing publications Daniel Skiest has written about Antifungal Agents.
Connection Strength
0.297
-
Iarikov D, Robertson D, Granowitz E, Skiest D. Images in HIV/AIDS. Invasive aspergillosis presenting as a neck mass in a person with HIV/AIDS. AIDS Read. 2007 Jul; 17(7):343-4.
Score: 0.065
-
Vazquez JA, Skiest DJ, Tissot-Dupont H, Lennox JL, Boparai N, Isaacs R. Safety and efficacy of posaconazole in the long-term treatment of azole-refractory oropharyngeal and esophageal candidiasis in patients with HIV infection. HIV Clin Trials. 2007 Mar-Apr; 8(2):86-97.
Score: 0.063
-
Vazquez JA, Skiest DJ, Nieto L, Northland R, Sanne I, Gogate J, Greaves W, Isaacs R. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. Clin Infect Dis. 2006 Apr 15; 42(8):1179-86.
Score: 0.059
-
Skiest DJ, Hester LJ, Hardy RD. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature. J Infect. 2005 Dec; 51(5):e289-97.
Score: 0.058
-
Goldman M, Zackin R, Fichtenbaum CJ, Skiest DJ, Koletar SL, Hafner R, Wheat LJ, Nyangweso PM, Yiannoutsos CT, Schnizlein-Bick CT, Owens S, Aberg JA. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis. 2004 May 15; 38(10):1485-9.
Score: 0.052